Share this article
FORT LAUDERDALE, Fla., Feb. 17, 2021 /PRNewswire/
ChronWell, Inc., a digital health and technology-enabled remote care management company, today announced that Stephen Harrison, MD, FACP, FAASLD, has been added to the company s Board of Advisors. I am excited about the prospect of working with the ChronWell team to further it s important work in using data and digital tools to help patients and practices together achieve better outcomes, said Dr. Harrison. With ChronWell s deep experience in harnessing clinical data, and scientific approach, I m anticipating great strides in digital healthcare in a variety of specialties, beginning with gastroenterology and liver disease.
/PRNewswire/ Watermark Retirement Communities ("Watermark") has become aware of a data security incident that may have involved the personal information of.
SC Labs Launches PhytoFacts® to Provide Advanced Chemometrics Reporting That Will Redefine How We Shop for Cannabis
New testing reports will establish more appropriate markers for quality and for predicting effects through chemical composition
News provided by
Share this article
Ⓡ. Clients testing cannabis through the lab will now have access to this game-changing reporting format and algorithm that provides a visual profile of each strain s chemical makeup. The company aims to lead the conversation away from the indica and sativa, or the THC potency race, and begin defining cannabis through its chemometric strain characterizations.
SC Labs The problem is that there is little standardization when it comes to defining and determining terpenes, according to Josh Wurzer, co-founder and President of SC Labs. Many of the largest flower and concentrate brands are promoting terpene content in a less than ideal manner. Cultivators, processors, retailers, and consumers could bene
Study Training Dogs To Detect Prostate Cancer Gets One Paw Closer To A Robotic Nose To Diagnose The Disease, Including Most Lethal Form
A study by Medical Detection Dogs, the Prostate Cancer Foundation, Massachusetts Institute of Technology, and Johns Hopkins University combined three current methods of diagnosing the disease for the first time to detect prostate cancer early
Larger-scale studies planned to develop a machine olfaction diagnostic tool - a robotic nose - that may ultimately be a smartphone app of the future; MIT developing prototype
News provided by
Share this article
Share this article
MILTON KEYNES, England and LOS ANGELES, Feb. 17, 2021 /PRNewswire/ New research from a multi-national, cross-disciplinary team of scientists from Medical Detection Dogs (MDD) in the UK, the Prostate Cancer Foundation (PCF), Massachusetts Institute of Technology (MIT), Johns Hopkins University – and a friendly pair of specially trained cancer-sniffing dogs at MDD – has
Share this article
Share this article
PHOENIX, Feb. 17, 2021 /PRNewswire/ Item 9 Labs Corp. (OTCQX: INLB) ( Item 9 Labs or the Company ), a vertically integrated cannabis operator that produces premium products, today announced that Andrew Bowden, CEO of Item 9 Labs, will present live to an online audience at the Benzinga Cannabis Capital Conference being held February 25-26, 2021. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis sector.
Item 9 Labs Presentation at Benzinga Cannabis Capital Conference
- DATE: Thursday, February 25, 2021
- TIME: 11:30 AM Eastern Time
Bowden will provide an overview of the Company, including its award-winning products, the ongoing operations expansion and other key initiatives, as well as the growth opportunities resulting from the favorable regulatory environment. He also plans to speak in-depth on why franchising is the growth vehicle that will propel the ca